title: Severe myositis on commencement of efavirenz, abacavir and lamivudine, in the absence of lactic acidosis or classical abacavir hypersensitivity.
abstract: Myositis in HIV may be due to HIV itself, or to opportunistic infection, malignancy or drug treatment. Severe myositis or rhabdomyolysis have never been reported with the commonly used nucleoside reverse transcriptase inhibitor abacavir, although creatine phosphokinase may rise modestly, particularly if abacavir hypersensitivity occurs. We report an unusual case of abacavir use associated with a thousand-fold rise in creatine phosphokinase in the absence of features of hypersensitivity. The case was also notable firstly in that there was an absence of the HLA-B5701 allele, the most common human leucocyte antigen (HLA) allele associated with hypersensitivity, and, secondly, as the case occurred in an African patient, African people not being prone to abacavir hypersensitivity.
authors.affiliation: Castle Hill Hospital, Infectious Diseases, Main Admin Block, Castle Road, Cottingham HU16 5JG, UK.
authors.forename: Mirella Jane
authors.initials: MJ
authors.lastname: Parsonage
authors.forename: Gavin
authors.initials: G
authors.lastname: Barlow
authors.forename: Patrick
authors.initials: P
authors.lastname: Lillie
authors.forename: Peter
authors.initials: P
authors.lastname: Moss
authors.forename: Katherine
authors.initials: K
authors.lastname: Adams
authors.forename: Hiten
authors.initials: H
authors.lastname: Thaker